Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBNK
901
DELISTED
Territorial Bancorp Inc.
TBNK
| $17.1M | 0.02% |
549,600
+46,700
| +9% | +$1.51M |
|
|
HOUS
902
DELISTED
Anywhere Real Estate
HOUS
| $17.1M | 0.02% |
574,900
-1,374,600
| -71% | -$37.4M |
|
|
ENZ
903
DELISTED
Enzo Biochem, Inc.
ENZ
| $17.1M | 0.02% |
2,042,400
+76,900
| +4% | +$542K |
|
904
Moelis & Co
MC
$5.1B
| $17.1M | 0.02% |
443,860
+219,860
| +98% | +$7.96M |
|
|
CPL
905
DELISTED
CPFL Energia S.A.
CPL
| $17.1M | 0.02% |
1,041,511
+204,125
| +24% | +$3.31M |
|
|
VEDL
906
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $17.1M | 0.02% |
993,800
+182,600
| +23% | +$2.76M |
|
907
Reading International Class A
RDI
$33.2M
| $17M | 0.02% |
1,092,500
-1,900
| -0.2% | -$30.8K |
|
908
Lam Research
LRCX
$337B
| $16.9M | 0.02% |
1,320,000
-1,110,000
| -46% | -$13M |
|
909
Mercer International
MERC
$45.6M
| $16.9M | 0.02% |
1,445,800
+121,100
| +9% | +$1.43M |
|
910
Sun Life Financial
SLF
$46.6B
| $16.9M | 0.02% |
462,100
+276,400
| +149% | +$10.5M |
|
|
MMP
911
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $16.9M | 0.02% |
+219,593
| New | +$17M |
|
|
SN
912
DELISTED
Sanchez Energy Corporation
SN
| $16.8M | 0.02% |
1,765,598
+62,398
| +4% | +$698K |
|
913
SS&C Technologies
SSNC
$18.8B
| $16.8M | 0.02% |
475,100
+339,800
| +251% | +$11.4M |
|
|
SPIL
914
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $16.8M | 0.02% |
2,070,543
+250,374
| +14% | +$1.94M |
|
|
FPRX
915
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $16.7M | 0.02% |
+462,901
| New | +$20.4M |
|
|
XLNX
916
DELISTED
Xilinx Inc
XLNX
| $16.7M | 0.02% |
288,399
-1,035,206
| -78% | -$60.8M |
|
|
JIVE
917
DELISTED
Jive Software, Inc.
JIVE
| $16.7M | 0.02% |
3,879,700
+532,800
| +16% | +$2.26M |
|
|
QADA
918
DELISTED
QAD Inc.
QADA
| $16.7M | 0.02% |
598,877
+25,800
| +5% | +$744K |
|
|
BPL
919
DELISTED
Buckeye Partners, L.P.
BPL
| $16.6M | 0.02% |
242,534
-388,900
| -62% | -$26.5M |
|
|
BMCH
920
DELISTED
BMC Stock Holdings, Inc
BMCH
| $16.5M | 0.02% |
731,600
+635,600
| +662% | +$12.9M |
|
921
Inogen
INGN
$174M
| $16.5M | 0.02% |
212,443
+65,743
| +45% | +$4.56M |
|
|
CELG
922
DELISTED
Celgene Corp
CELG
| $16.4M | 0.02% |
132,138
-619,200
| -82% | -$74.1M |
|
|
ZNH
923
DELISTED
China Southern Airlines Company Limited
ZNH
| $16.4M | 0.02% |
493,900
+6,900
| +1% | +$212K |
|
924
Descartes Systems
DSGX
$6.48B
| $16.4M | 0.02% |
715,500
+153,600
| +27% | +$3.38M |
|
|
CLDT
925
Chatham Lodging
CLDT
$638M
| $16.3M | 0.02% |
827,100
-144,700
| -15% | -$2.91M |
|
Similar funds
Renaissance Technologies's Q1 2017 Portfolio in Review
As of Q1 2017, Renaissance Technologies held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Renaissance Technologies's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Renaissance Technologies added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Renaissance Technologies's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Renaissance Technologies fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Renaissance Technologies opened 433 new positions and closed 462 in Q1 2017.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.